AbbVie Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Total-Other-Income-Expense-Net" stands at -10.18 Billion United States Dollars for the trailing twelve months (TTM) period ending 06/30/2026.
AbbVie Inc's second quarter result of -2.15 Billion USD for the item "Total Other Income Expense Net" represents an increase of 41.71 percent compared to it's first quarter result.
Also, AbbVie Inc's second quarter result of -2.15 Billion USD for the item "Total Other Income Expense Net" represents an increase of 35.51 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), AbbVie Inc's second quarter result of -10.18 Billion USD for the item "Total Other Income Expense Net" represents an increase of 10.43 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -2.24 Billion United States Dollars compared to the value the year prior.
The 1 year change is -2.24 Billion United States Dollars.
The 3 year change is -3.24 Billion United States Dollars.
The 5 year change is -0.651 Billion United States Dollars.
The 10 year change is -8.96 Billion United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Other Income Expense Net | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Other Income Expense Net | 486,508,953,600.00 |
![]() | Roche Holding AG - Total Other Income Expense Net | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Other Income Expense Net | 280,205,508,085.11 |
![]() | Novartis AG - Total Other Income Expense Net | 255,096,620,580.91 |